Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight loss ...
ABC News' Dr. Tara Narula breaks down the FDA's decision to stop the making of compound versions of weight loss medications.
These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...
U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...
After being exposed to toxins from the LA fires, some firefighters are turning to a compounded breathing drug, but it's hard ...